Consistent findings demonstrated that METTL3 is significantly upregulated in bladder cancer, knockdown of which dramatically repressed cancerous cell proliferation, invasion, and xenograft tumor formation via AFF4/NF-kB/Myc axis signaling pathway199. This evidence concerns the gene METTL3 and urinary bladder cancer.